https://www.insideprecisionmedicine.com/topics/oncology/leukemia/promising-menin-inhibitor-results-from-leukemia-trial-published/
0
0
3/16/23 at 2:34pm
Organization
Insideprecisionmedicine.com
Author
Malorye Branca
34 words
0
Comments
Syndax’s revumenib shows promise in advanced acute leukemias with KMT2A rearrangements or mutant NPM1, according to findings published this week in Nature.
You are the first to view
Create an account
or login to join the discussion